CollPlant Biotechnologies Ltd — Cash Flow (NASDAQ:CLGN)

Financials

Cash from operating activities 4.45 M2.5 M13.7 M2.76 M14.09 M — Cash from investing activities 519 K31.56 M28.92 M1.16 M539 K — Cash from financing activities 4.46 M38.76 M1.87 M1.11 M9 000 — Free cash flow 3.93 M912 K12.38 M1.81 M13.61 M —

뉴스

CollPlant secures Korean patent for dermal filler technology

CollPlant launches BioFlex bioink kit for 3D bioprinting

CollPlant 주식, D. Boral Capital, ’매수’에서 ’보유’로 하향 조정

CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital

CollPlant Biotechnologies, 12월 31일 연례 및 임시 주주총회 개최

CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31

Collplant ADR Q3 실적, 수익 에상치보다 저조

Collplant ADR earnings missed by $0.41, revenue fell short of estimates

CollPlant, 3분기 매출 예상치 하회…주가 소폭 하락

CollPlant shares edge down as Q3 revenue falls short of estimates

CollPlant, 북미 유통망 확대 위해 물류 허브 구축

CollPlant expands North American distribution with new logistics hub